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ell-controlled HIV patients. The occurrence of these complica-
ions has brought to the surface the need for a better understanding
f organ transplantation in this population. Their care is complex
nd requires expertise. Issues of graft survival, opportunistic infec-
ions, an increase in comorbidities, and the various interactions
etween the immunosuppressive drugs and the antiretrovirals, are
ll situations that present a challenge to the infectious diseases
ractitioner. In this lecture, Dr. Brito will review the most com-
on indications for liver and kidney transplants, the epidemiology,
ost surgical outcomes, and some special management scenarios
ncountered in clinical practice.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.144
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ommon respiratory viral infections
. Kaiser
Laboratoire de Virologie, Geneva, Switzerland
Respiratory viruses are certainly the most common viruses
nfecting humans. Thanks to the availability of modern molecu-
ar screening these viruses are frequently recovered in the upper or
he lower respiratory tract of hospitalized patients. It is thus impor-
ant to understand not only the epidemiology but also the potential
linical impact of these agents. Across all population studied the
ost frequent viruses are the so-called common cold viruses like
hinoviruses and coronaviruses. What is the real impact of these
iruses, are they innocent bystanders? Are these viruses causing
espiratory symptoms and lower respiratory tract infections? The
iological and clinical diversity of viral respiratory diseases will
e reviewed as well as the epidemiology and the clinical conse-
uences of these infections in transplant recipients. Large cohorts
tudies conducted in lung transplant recipients will be presented.
he potential available treatment interventions in transplant recip-
ents will also be discussed.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.145
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onfronting tuberculosis in the era of HIV
. Lawn
University of Cape Town, Cape Town, South Africa
The HIV-associated tuberculosis (TB) epidemic remains a huge
hallenge to TB control in countrieswithhighprevalenceofHIVand
s a substantial obstacle to progress towards attainment of the Mil-
ennium Development Goals and associated STOP TB targets for TB
ontrol. This talk will summarize the current approach to control
f this epidemic and then will focus in detail on two key issues.nfectious Diseases 16S (2012) e2–e157 e59
(i) The huge challenge of diagnosis of HIV-associated TB funda-
mentally undermines our response to this epidemic. This talk will
review the very promising developments in TB diagnostics that for
the ﬁrst time permit rapid and point-of-care diagnosis of sputum
smear-negative TB in patients with advanced immunodeﬁciency.
(ii) It is abundantly clear that we cannot treat our way out of this
epidemic using the DOTS TB control strategy and additional TB pre-
ventive intervention are needed. This talk will highlight the impact
of ART to serve as the key TB preventive intervention, describing
in detail its impact on individual risk as well as the impact at the
community level. The preventive potential of ART is largely being
squandered at present and the potential for the ‘Test and Treat’
strategy to have a much greater impact will be discussed.
http://dx.doi.org/10.1016/j.ijid.2012.05.146
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Innate immune recognition and response to pathogens
S. Akira
Osaka University, Osaka, Japan
Our laboratory studies mechanisms of innate immunity.
Through generation of knockout mice, we have demonstrated
that a family of Toll-like receptors (TLR) recognizes a variety of
PAMPs such as lipopolysaccharide, lipoprotein and nucleic acids
derived frombacteria, viruses andprotozoa to elicit innate immune
responses. We have also demonstrated that a family of RIG-I-like
RNA helicases (RLR) including RIG-I and MDA5 participates in TLR-
independent recognition of nucleic acids derived from different
types of RNA viruses in the cytoplasm. NOD-like receptors(NLR)
also sense microbial components in the cytoplasm of cells. Several
C-type lectin receptors(CLR) are shown to recognize the carbohy-
drates frompathogens.Here Iwill talk about the anti-viral response
by neutrophil extracellular DNA trap(NET) and ZAP.
http://dx.doi.org/10.1016/j.ijid.2012.05.147
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Innate immune recognition of an AT-rich stem-loop DNA motif
in the Plasmodium falciparum genome
D. Golenbock
University Massachusetts Medical School, Worcester, MA, USA
Malarial infections lead to signiﬁcant morbidity and mortal-
ity worldwide. The genome ofPlasmodium falciparumis the most
AT-rich of any genome studied; it has over 6000 ATTTTTAC (“AT-
rich”) motifs, which we now show activate human and murine
cells to produce inﬂammatory cytokines and type I Interferons.
Induction of type I IFNs byPlasmodium-derived AT-rich DNA is
